Cargando…
Blood microbiota and metabolomic signature of major depression before and after antidepressant treatment: a prospective case–control study
BACKGROUND: The microbiota interacts with the brain through the gut–brain axis, and a distinct dysbiosis may lead to major depressive episodes. Bacteria can pass through the gut barrier and be found in the blood. Using a multiomic approach, we investigated whether a distinct blood microbiome and met...
Autores principales: | Ciocan, Dragos, Cassard, Anne-Marie, Becquemont, Laurent, Verstuyft, Céline, Voican, Cosmin Sebastian, El Asmar, Khalil, Colle, Romain, David, Denis, Trabado, Séverine, Feve, Bruno, Chanson, Philippe, Perlemuter, Gabriel, Corruble, Emmanuelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Joule Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327971/ https://www.ncbi.nlm.nih.gov/pubmed/34008933 http://dx.doi.org/10.1503/jpn.200159 |
Ejemplares similares
-
Liver Function Test Abnormalities in Depressed Patients Treated with Antidepressants: A Real-World Systematic Observational Study in Psychiatric Settings
por: Voican, Cosmin Sebastian, et al.
Publicado: (2016) -
The MAOA rs979605 Genetic Polymorphism Is Differentially Associated with Clinical Improvement Following Antidepressant Treatment between Male and Female Depressed Patients
por: Chappell, Kenneth, et al.
Publicado: (2022) -
Human Dermal Fibroblast: A Promising Cellular Model to Study Biological Mechanisms of Major Depression and Antidepressant Drug Response
por: Mesdom, Pierre, et al.
Publicado: (2020) -
The association of ARRB1 polymorphisms with response to antidepressant treatment in depressed patients
por: Chappell, Kenneth, et al.
Publicado: (2022) -
Non-overweight depressed patients who respond to antidepressant treatment have a higher risk of later metabolic syndrome: findings from the METADAP cohort
por: El Asmar, K., et al.
Publicado: (2023)